INSP
Inspire Medical Systems Inc
$
155.340
- Overview
- Forecast
- Valuation
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
158.600
Open
158.600
VWAP
157.64
Vol
21.79K
Mkt Cap
4.76B
Low
155.540
Amount
3.43M
EV/EBITDA(TTM)
99.71
Total Shares
29.71M
EV
4.26B
EV/OCF(TTM)
32.71
P/S(TTM)
5.96
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
FY2025Q1
241.76M
+18.98%
0.692
+15.3%
227.70M
+16.24%
0.407
+27.22%
194.93M
+18.85%
-0.233
-31.45%
Estimates Revision
The market is revising Upward the revenue expectations for Inspire Medical Systems, Inc. (INSP) for FY2025, with the revenue forecasts being adjusted by 0.06% over the past three months. During the same period, the stock price has changed by -20.23%.
Revenue Estimates for FY2025
Revise Upward
+0.06%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+10.6%
In Past 3 Month
Stock Price
Go Down
-20.23%
In Past 3 Month
14 Analyst Rating
43.70% Upside
Wall Street analysts forecast INSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INSP is 223.23 USD with a low forecast of 190.00 USD and a high forecast of 270.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
3 Hold
0 Sell
Strong Buy
43.70% Upside
Current: 155.340
Low
190.00
Averages
223.23
High
270.00
43.70% Upside
Current: 155.340
Low
190.00
Averages
223.23
High
270.00
Keybanc
Tim Rezvan
Buy
Maintains
$234 → $216
2025-04-21
Reason
Keybanc
Tim Rezvan
Price Target
$234 → $216
2025-04-21
Maintains
Buy
Reason
KeyBanc lowered the firm's price target on Inspire Medical to $216 from $234 and keeps an Overweight rating on the shares. The firm believes underlying MedTech trends remain mostly positive heading into Q1 earnings season, but is lowering several price targets to reflect macro concerns around the potential impact of tariffs as well as an increased risk of recession.
Stifel
Jonathan Block
Hold
Maintains
$190 → $175
2025-04-21
Reason
Stifel
Jonathan Block
Price Target
$190 → $175
2025-04-21
Maintains
Hold
Reason
Stifel lowered the firm's price target on Inspire Medical to $175 from $190 and keeps a Hold rating on the shares. While Inspire's valuation has "become more attractive of late" and the company "appears well positioned for any tariff twists and turns," the firm sees some "choppy waters ahead" and believes news flow might act as an overhang to Inspire shares over the next six months, the analyst tells investors.
RBC Capital
Shagun Singh
Buy
Maintains
$260 → $215
2025-04-15
Reason
RBC Capital
Shagun Singh
Price Target
$260 → $215
2025-04-15
Maintains
Buy
Reason
RBC Capital analyst Shagun Singh lowered the firm's price target on Inspire Medical to $215 from $260 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results for Medical Devices. Q1 underlying procedure volume and capital placements trends were solid with typical seasonality at play, which should position companies under coverage to beat expectations for the quarter, while FX has moved notably to favor large-cap medical device companies with international exposure, which is not factored into consensus estimates for Q1 or 2025, the analyst tells investors in a research note. Tariff impact is likely to be clarified by several companies, though many companies under coverage have low tariff exposure with a substantial U.S. manufacturing footprint or low relative exposure vs. other large caps, the firm adds.
Morgan Stanley
Kallum Titchmarsh
Buy
Maintains
$230 → $220
2025-02-11
Reason
Morgan Stanley
Kallum Titchmarsh
Price Target
$230 → $220
2025-02-11
Maintains
Buy
Reason
Morgan Stanley lowered the firm's price target on Inspire Medical to $220 from $230 and keeps an Overweight rating on the shares. Though revenues for Q4 and 2025 guidance were known following January's pre-announcement, the firm was "impressed" with Inspire's "continued outperformance below the topline," the analyst tells investors. The civil investigative demand from the Department of Justice U.S. Attorney's Office for the District of Minnesota that the company disclosed is "a mild annoyance but manageable," the analyst added.
Wells Fargo
Larry Biegelsen
Hold
Maintains
$198 → $195
2025-02-11
Reason
Wells Fargo
Larry Biegelsen
Price Target
$198 → $195
2025-02-11
Maintains
Hold
Reason
Wells Fargo lowered the firm's price target on Inspire Medical to $195 from $198 and keeps an Equal Weight rating on the shares. On February 10, Inspire Medical reported Q4 profitability and gave 2025 EPS guide above consensus. Inspire V inventory build remains gating factor to full launch, the firm notes. CID investigation may be an overhang, adds Wells.
Baird
Mike Polark
Buy
Maintains
$252 → $248
2025-02-11
Reason
Baird
Mike Polark
Price Target
$252 → $248
2025-02-11
Maintains
Buy
Reason
Baird lowered the firm's price target on Inspire Medical to $248 from $252 and keeps an Outperform rating on the shares. The firm said the risk/reward remains to the upside and the 2025 growth/profit outlook remains in check.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Inspire Medical Systems Inc (INSP.N) is 73.13, compared to its 5-year average forward P/E of -9.13. For a more detailed relative valuation and DCF analysis to assess Inspire Medical Systems Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-9.13
Current PE
73.13
Overvalued PE
211.34
Undervalued PE
-229.61
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-38.82
Current EV/EBITDA
23.52
Overvalued EV/EBITDA
132.40
Undervalued EV/EBITDA
-210.04
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
14.92
Current PS
4.99
Overvalued PS
22.81
Undervalued PS
7.03
Financials
Annual
Quarterly
FY2024Q4
YoY :
+24.52%
239.72M
Total Revenue
FY2024Q4
YoY :
+242.95%
31.88M
Operating Profit
FY2024Q4
YoY :
+138.60%
35.22M
Net Income after Tax
FY2024Q4
YoY :
+132.00%
1.16
EPS - Diluted
FY2024Q4
YoY :
+573.10%
62.15M
Free Cash Flow
FY2024Q4
YoY :
-0.52%
84.99
Gross Profit Margin - %
FY2024Q4
YoY :
+6993.75%
11.35
FCF Margin - %
FY2024Q4
YoY :
+91.53%
14.69
Net Margin - %
FY2024Q4
8.48
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
1.2M
USD
2
3-6
Months
6.5M
USD
4
6-9
Months
4.2M
USD
4
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
15.3K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
60.0K
Volume
1
6-9
Months
0.0
Volume
0
0-12
Months
223.6K
Volume
2
Bought
0-3
0
0.0
Volume
Months
3-6
4
961.7K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
12
1.5M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
1.2M
USD
2
3-6
Months
6.5M
USD
4
6-9
Months
4.2M
USD
4
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
15.3K
USD
Months
0-12
0
0.0
USD
Months
INSP News & Events
Events Timeline
2025-04-21 (ET)
2025-04-21
08:13:16
Inspire Medical adds Paul Hoff, Ruchir Patel as VP, senior medical directors
2025-02-10 (ET)
2025-02-10
15:33:57
Inspire Medical discloses civil investigative demand from DOJ
2025-02-10
15:06:02
Inspire Medical sees FY25 EPS $2.10-$2.20, consensus $1.94
Sign Up For More Events
Sign Up For More Events
News
4.0
04-15BenzingaWhat Analysts Are Saying About Inspire Medical Systems Stock
4.0
04-15BenzingaRBC Capital Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $215
1.0
03-18NASDAQ.COMInspire Medical Systems To Present At KeyBanc Capital Markets Healthcare Forum; Webcast At 3:00 PM
Sign Up For More News
People Also Watch
RYAM
Rayonier Advanced Materials Inc
4.160
USD
-3.93%
SVRA
Savara Inc
3.215
USD
-1.38%
AGS
PlayAGS Inc
12.090
USD
-0.17%
CLW
Clearwater Paper Corp
26.705
USD
+6.78%
PROK
ProKidney Corp
1.030
USD
-4.63%
IVR
Invesco Mortgage Capital Inc
7.287
USD
-2.45%
ALRS
Alerus Financial Corp
19.970
USD
-0.75%
DOYU
Douyu International Holdings Ltd
7.400
USD
-1.60%
ANGO
AngioDynamics Inc
9.360
USD
-2.30%
ATRO
Astronics Corp
22.170
USD
-2.08%
FAQ
What is Inspire Medical Systems Inc (INSP) stock price today?
The current price of INSP is 155.34 USD — it has decreased -2.87 % in the last trading day.
What is Inspire Medical Systems Inc (INSP)'s business?
What is the price predicton of INSP Stock?
What is Inspire Medical Systems Inc (INSP)'s revenue for the last quarter?
What is Inspire Medical Systems Inc (INSP)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Inspire Medical Systems Inc (INSP)'s fundamentals?
How many employees does Inspire Medical Systems Inc (INSP). have?